Testing effectiveness (Phase 2)Looking for participantsNCT06962787
What this trial is testing
BL-B01D1+TKI±Pembrolizumab in Patients With Locally Advanced or Metastatic Renal Cancer
Who this might be right for
Renal Cancer
Sichuan Baili Pharmaceutical Co., Ltd. 260